"Illegal medical practice." That's what the Chinese court called it when Dr. He Jiankui created Lulu and Nana — the first genetically modified human beings. Not "crimes against humanity." Not "reckless experimentation on children." Illegal medical practice. Like he was writing prescriptions without a license.
That framing stuck with me somewhere around hour 3 on a Tuesday commute, staring at my reflection in the Caltrain window, and I couldn't shake it for the rest of the book.
The CRISPR Bug Report Nobody's Triaging
TL;DR: Worth your commute if you want the full-stack view of gene editing — not just the science, but the economics, disability rights arguments, and geopolitical chess game surrounding it.
Eben Kirksey is an anthropologist, not a geneticist, and honestly that's the book's superpower. He's not trying to explain CRISPR mechanisms for the hundredth time (though he covers enough to keep you oriented). Instead he's doing something I found way more interesting: mapping the entire ecosystem around genetic modification. Think of it as — okay, imagine someone wrote a book about distributed systems, but instead of just covering consensus algorithms, they also interviewed the on-call engineers, the VCs funding the startups, the patients whose data flows through the pipeline, and the regulators who are three years behind the technology. That's this book.
Kirksey visits biohacker labs where people are injecting themselves with DIY gene therapies. He talks to disabled scholars who push back hard on the assumption that genetic "correction" is inherently good — and these were some of the most uncomfortable, productive sections of the whole listen. He hangs out with lobbyists in DC and researchers in Indonesia and China, building this picture of a global race where the rules are being written (or not written) in real time.
The He Jiankui case is the throughline, but the book sprawls outward from there. Kirksey traces how loosening regulations in places like the US and Indonesia are creating this patchwork system where access to gene editing tech will almost certainly track with wealth and race. It's basically the "who gets to deploy to production" problem, but for human genetics, and the access control is broken.
The same broken access control patterns show up in Eating Animals — different domain, same uncomfortable questions about who gets to opt out and who doesn't.Where the Build Breaks
Here's where I have to be honest: this is an 11-hour listen that probably should've been 8. Kirksey is clearly a thorough researcher, and he's published in Wired and The Atlantic, so the guy can write. But the anthropological style means you get a LOT of scene-setting — who he met, what the room looked like, what they ate. Sometimes that's great for establishing trust in the reporting. Other times, around hour 7 on a Friday evening commute when I was running on caffeine and spite after a bad deploy, I found my attention drifting.
And then there's Jonathan Todd Ross. Look, he's clear. You can understand every word. I never had to rewind because of mumbling or weird pacing. But — and I feel bad saying this because the content deserves better — the delivery is pretty wooden. For a book about something this wild, this ethically charged, the narration lands flat in places that should hit hard. When Kirksey is describing parents agonizing over whether to genetically modify embryos to prevent devastating diseases, I want the narrator to at least sound like he's in the room. Instead it reads more like someone reading a well-written term paper aloud. Clear and easy to understand? Yes. Engaging? Not consistently.
I bumped this up to 1.5x (my default) and honestly it helped — tightened up some of the slower descriptive passages without losing the science.
Who Should Plug In (and Who Should Skip)
Perfect for: train, gym. Skip for: bedtime (the wooden narration + academic pacing will put you out before the good parts).
If you're in tech and you've been casually following CRISPR news through blog posts and podcast episodes, the ROI on this audiobook is solid — it connects dots you didn't know existed between the science, the money, and the ethics. Kirksey's anthropological lens means you get perspectives (disability rights activists, biohackers, Indonesian researchers) that the standard Silicon Valley techno-optimist coverage completely ignores.
If you want hard science deep-dives into the actual gene editing mechanisms, this isn't it. Go grab a molecular biology textbook. This is the sociotechnical map, not the API docs.
Kevin asked me what I was listening to and I described it as "basically The Immortal Life of Henrietta Lacks but for CRISPR" and that's... not a bad comp, actually. Similar energy of an outsider-to-the-field journalist pulling back the curtain on who benefits and who gets harmed when science moves faster than ethics committees.
Ship It, But Patch the Narrator
The content here is genuinely important and Kirksey earned my trust as a reporter. The science holds up where he presents it, and the ethical questions he raises aren't the easy ones. I walked away from this one thinking differently about disability, about who gets to define "normal," and about how breathtakingly fast this field is moving while most of us aren't paying attention. But the narration is a tax on the experience — you're paying an attention premium that the material shouldn't require. I finished this in about 5 commutes and I'm glad I did. I just wish the audio performance matched the urgency of what's actually being said.
